Suros Surgical Systems is an Indiana-based medical device manufacturer specializing in minimally invasive tissue excision and biopsy technology. Their flagship product, the patented ATEC™ (Automated Tissue Excision and Collection) breast biopsy and excision system, has revolutionized vacuum-assisted diagnostic breast biopsy, offering early diagnosis opportunities for high-risk women. The company's commitment to a minimally invasive approach ensures patients receive top-notch care, with the ATEC™ system delivering substantial improvements in speed, reliability, clinical capabilities, safety, economic efficiency, and ease of use. In August 2004, the company secured a $12.00M Venture Round investment from notable investors including River Cities Capital Funds, Twilight Venture Partners, Rose-Hulman Ventures, Piper Jaffray, and Morgan Stanley Expansion Capital. Suros continues to lead the way in developing new capabilities for minimally invasive tissue excision, making significant strides in the field of biotechnology, healthcare, medical devices, and robotics.